Глобальный рынок прокариотических систем экспрессии – тенденции отрасли и прогноз до 2029 года

 Анализ и размер рынка прокариотических систем экспрессии

Прокариотическая система является наиболее широко используемой системой для перепроизводства белка как в лабораторных условиях, так и в промышленности. Эта система в первую очередь основана на бактериях E. coli, хотя виды Bacillus все чаще используются. Прокариотическая система позволяет быстро производить большие количества рекомбинантных белков. Использование этих микроорганизмов облегчается простой и недорогой культурой бактериальных клеток и хорошо известными механизмами транскрипции и трансляции. Прокариотическая система также имеет то преимущество, что ее легко модифицировать генетически и она имеет большое количество доступных бактериальных мутантов.

Компания Data Bridge Market Research анализирует, что рынок прокариотических систем экспрессии, который в 2021 году составил 294,49 млн долларов США, как ожидается, достигнет 808,17 млн ​​долларов США к 2029 году при среднегодовом темпе роста 13,45% в прогнозируемый период с 2022 по 2029 год. Помимо информации о рыночных сценариях, таких как рыночная стоимость, темпы роста, сегментация, географический охват и основные игроки, рыночные отчеты, подготовленные компанией Data Bridge Market Research, также включают в себя углубленный экспертный анализ, эпидемиологию пациентов, анализ конвейера, анализ цен и нормативную базу.

Масштаб и сегментация рынка прокариотических систем экспрессии  

Market Definition

The prokaryotic expression system is one of the most commonly used genetic engineering approaches for the expression and secretion of exogenous target genes. The vector and the expression host are the basic elements of any expression system. The prokaryotic system is the most widely used system for protein overproduction, both in the laboratory and in industry. This system is primarily based on the bacteria E. coli, though Bacillus species are increasingly being used.

Global Prokaryotic Expression Systems Market Dynamics

Drivers

• Rising use of E. coli bacteria

The market is expanding due to the large-scale production of a protein using E. coli bacteria, as E. coli is the most commonly used artificial expression host. E. coli is widely used because of its genomic and physiological sequencing system, which is responsible for simplifying the cloning procedure and making the E. coli host the most popular in the pharmaceutical industry. Furthermore, this process is responsible for increasing the binding strength of promoter region 7 and aiding in transcription. Furthermore, prokaryotic expression is critical in the pharmaceutical and biotechnology industries. These factors are expected to boost growth.

• Research and development activities to bolster the growth

The market for prokaryotic expression systems is dominated by the research and applications. The segment's growth is attributed to the large-scale application and benefits such as prokaryotes' rapid growth and use in molecular biology, genetics, and biochemistry research. Prokaryotic organisms are essential to all living organisms and play an important role in recycling nutrients by decomposing dead organisms. As a result of this, they are widely used in research as healthy bacteria. Furthermore, studies are being conducted to improve the activity of prokaryotic in the pharmaceutical and biotechnology industries in order to improve the action of pharmaceutical drugs. However, the current trend of moving genetic parts from prokaryotic to eukaryotic for the corresponding DNA-binding sequencing by E. coli is likely to boost the market growth.

Opportunities

• Technological development to create opportunities

Increasing advancement in genomic sequences along with technological advancement for instance, in April 2020, Bio-Rad laboratories, Inc., a leading life science research organisation based in the United States, acquired Celsee, Inc. to provide instruments and consumables for the isolation, detection, and analysis of single cells.in proteomics which will further boost various opportunities for the growth of the prokaryotic expression systems market in the above mentioned forecast period.

Restraints/Challenges

• High cost of protein expression

High barrier on the entry of the new organisation along with high cost of protein expression reagents will obstruct the market's growth rate. Limited disease awareness, high product costs, poor economic conditions, and a lack of favourable insurance systems all limit the adoption of prokaryotic expression systems products in developing regions around the world.

This prokaryotic expression systems market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the prokaryotic expression systems market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent developments

• In April 2020, US-based leading life science research organization, Bio-Rad laboratories, Inc., acquired Celsee, Inc. to offers instruments and consumables for the isolation, detection, and analysis of single cells.

Global Prokaryotic Expression Systems Market Scope

The prokaryotic expression systems market is segmented on the basis of host type, product, application and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Host Type

• Archaea
• Bacillus Subtilis
• Corynebacterium Glutamicum
• Escherichia Coli Systems
• Pseudomonas Alcaligenes

 Product

• Amino Acids
• Biopolymers
• Ascorbic Acids
• Pigments
• Enzymes
• Antibiotics
• Lipases
• Instruments
• Competent Cells
• Reagents
• Expression Vectors
• Services

 Application

• Research Applications
• Therapeutic Proteins
• Industrial Proteins

End User

• Academic Research
• Biotechnological Companies
• Pharmaceuticals
• Contract Research Organizations

Prokaryotic Expression Systems Market Regional Analysis/Insights

The prokaryotic expression systems market is analysed and market size insights and trends are provided by country, host type, product, application and end user as referenced above.

The countries covered in the prokaryotic expression systems market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the prokaryotic expression systems market owing to factors such as continuous advancements to genome sequencing and innovations to proteomics in countries such as US and Canada.

Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2022 to 2029 due to the factors ascribing to the growth of the region are cumulative research studies carried out by the market players and growing investment in research and development activities gene expression is likely to motivate the market growth.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure Growth Installed base and New Technology Penetration

Рынок систем прокариотической экспрессии также предоставляет вам подробный анализ рынка для каждой страны по росту расходов на здравоохранение для капитального оборудования, установленной базы различных видов продукции для рынка систем прокариотической экспрессии, влияния технологий с использованием кривых жизненной линии и изменений в сценариях регулирования здравоохранения и их влияния на рынок систем прокариотической экспрессии. Данные доступны за исторический период 2010-2020 гг.

Анализ конкурентной среды и доли рынка прокариотических систем экспрессии

Конкурентная среда рынка систем экспрессии прокариот содержит сведения по конкурентам. Включены сведения о компании, финансы компании, полученный доход, рыночный потенциал, инвестиции в исследования и разработки, новые рыночные инициативы, глобальное присутствие, производственные площадки и объекты, производственные мощности, сильные и слабые стороны компании, запуск продукта, широта и широта продукта, доминирование приложений. Приведенные выше данные относятся только к фокусу компаний, связанному с рынком систем экспрессии прокариот.

Некоторые из основных игроков, работающих на рынке прокариотических систем экспрессии:

• Agilent Technologies, Inc. (США)
• Merck KGaA (Германия)
• Bio-Rad Laboratories, Inc. (США)
• QIAGEN (Германия)
• Корпорация Promega (США)
• Thermo Fischer Scientific, Inc. (США)
• Takara Bio Inc. (Япония)
• GenScript (США)
• New England Biolabs (США)
• Oxford Expression Technology (Великобритания)
• LifeSensors Inc. (США)
• Лонза (Швейцария)
• Протеогеникс (Франция)
• Synthetic Genomics Inc. (США)
• Peak Proteins Ltd (Великобритания)
• Sino Biological Inc. (Китай)
• ARTES Biotechnology GmbH (Германия)

SKU-55966